Home · ARTEBONE Revenue and Competitors

Oulu,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Home · ARTEBONE's estimated annual revenue is currently $3.8M per year.(i)
  • Home · ARTEBONE's estimated revenue per employee is $251,000

Employee Data

  • Home · ARTEBONE has 15 Employees.(i)
  • Home · ARTEBONE grew their employee count by -6% last year.

Home · ARTEBONE's People

NameTitleEmail/Phone
1
Production DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Home · ARTEBONE?

BBS-Bioactive Bone Substitutes (BBS) is a biomedical technology company developing innovative, biologically active medical device implants to be used in orthopedic surgery. Our first product, ARTEBONE®, is made from a natural animal source of bone material that has a superior capability of bone regeneration compared to existing products. Trading in the shares began on the First North Growth Finland marketplace under the share trading code ”BONEH” and on the First North Growth Sweden marketplace under the share trading code “BONES” on 28 February 2018. Stockholm Certified Advisers AB in Sweden acts as the Company's Certified Advisors under First North Nordic Rulebook.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3.8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M150%N/A
#2
$3.4M1614%N/A
#3
$3.4M20-5%N/A
#4
$3.5M215%N/A
#5
$2.2M22N/AN/A